Surgisphere Scandal
A tiny company behind three influential COVID studies falls apart under scrutiny. (Series selected as finalist for NIHCM trade journalism award.)
I am an experienced reporter and editor working on stories about life science research, medicine, and science policy. For my most recent pieces of writing, visit my pages at The Scientist and Science. Or see below for a selection of investigations, features, and editing work.
A tiny company behind three influential COVID studies falls apart under scrutiny. (Series selected as finalist for NIHCM trade journalism award.)
A physician accused of spreading COVID vaccine misinformation turns his followers against his critics. State medical boards decline to get involved.
The US clinical trials registry is racking up inaccurate and out-of-date study information, but nobody’s keeping track.
A COVID-related special issue at Frontiers goes off the rails after the publisher takes down a controversial paper.
Scientists look to intestinal parasites for solutions to autoimmune diseases.
An old idea gets a makeover as researchers dig into the mechanisms of learning and memory.
New therapeutic approaches in oncology aim to manipulate or block cancer evolution.
The reasons some pairs stick together and others split up are starting to come to light.
Researchers who alert scientific journals to errors in the literature often face an uphill battle.
A new initiative races to preserve datasets stored on outdated media before they’re lost forever.
The research community confronts scientists’ reluctance to share computational code.
Advanced imaging techniques offer a glimpse into the hidden world of millipede sex.